Volume 25, Number 1—January 2019
Synopsis
Clinical and Radiologic Characteristics of Human Metapneumovirus Infections in Adults, South Korea
Table 2
Co-detection of other pathogens and clinical course of patients infected with human metapneumovirus, South Korea*
Characteristic | Immunocompetent | Solid tumors | SOT | HCT | HM | Steroid use | Total |
---|---|---|---|---|---|---|---|
Total | 459 (54) | 174 (20) | 59 (7) | 9 (1) | 58 (7) | 90 (11) | 849 |
URI | 126 (28) | 68 (39) | 30 (51) | 1 (11) | 20 (35) | 27 (30) | 270 (32) |
LRD | 333 (73) | 106 (61) | 29 (49) | 8 (89) | 38 (66) | 63 (70) | 579 (68) |
Ribavirin use | 44 (10) | 22 (13) | 10 (17) | 5 (56) | 23 (40) | 22 (24) | 126 (15) |
IVIG use | 3 (1) | 0 | 1 (2) | 0 | 1 (2) | 3 (3) | 8 (1) |
Both ribavirin and IVIG use |
2 (0.4) |
0 |
0 |
0 |
0 |
1 (1) |
3 (0.4) |
Co-detection of other pathogen, n = 126 | |||||||
URI | 17 (13) | 18 (26) | 10 (33) | 1 (100) | 10 (50) | 7 (26) | 63 (23) |
LRD | 72 (21) | 23 (22) | 13 (45) | 1 (13) | 9 (24) | 22 (35) | 140 (24) |
Bacteria | 48 | 20 | 16 | 1 | 11 | 20 | 116 |
Virus | 32 | 14 | 7 | 0 | 6 | 5 | 64 |
Fungi | 3 | 5 | 0 | 1 | 0 | 0 | 9 |
Bacteria and virus | 6 | 1 | 0 | 0 | 2 | 3 | 12 |
Bacteria and fungi | 0 | 1 | 0 | 0 | 0 | 0 | 1 |
Virus and fungi |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
Hospital admission | 279 (65) | 98 (56) | 32 (54) | 6 (67) | 35 (60) | 64 (71) | 552 (65) |
Length of hospital stay, days | 6.0 (4.0–13.0) | 7.0 (4.0–12.0) | 6.0 (4.0–14.0) | 7.0 (5.3–55.3) | 10.5 (5.8–32.5) | 7.0 (4.0–16.0) | 7.0 (4.0–13.0) |
ICU admission | 42 (9) | 4 (2) | 5 (10) | 1 (11) | 5 (10) | 11 (12) | 68 (8) |
All-cause mortality rate at 30 d | 16 (3) | 17 (10) | 0 (0) | 2 (22) | 5 (9) | 7 (8) | 47 (6) |
All-cause mortality rate at 90 d | 18 (4) | 22 (13) | 1 (2) | 3 (33) | 7 (12) | 8 (9) | 59 (7) |
Overall mortality rate | 42 (9) | 34 (20) | 3 (5) | 4 (44) | 21 (36) | 22 (24) | 126 (15) |
*Values are no. (%) or median (interquartile range) unless otherwise indicated. HCT, hematologic stem cell transplantation; HM, hematologic malignancy; ICU, intensive care unit; IVIG, intravenous immunoglobulin; LRD, lower respiratory tract disease; SOT, solid organ transplants; URI, upper respiratory tract infection.